ENA-001

ENA-001
Clinical data
Routes of; administration	IV
ATC code	None;
Legal status
Legal status	US: Investigational New Drug;
Identifiers
	IUPAC name 2-[(N-Methyl-N-methoxy)amino]-4,6-bis(propylamino)-1,3,5-triazine;
JSmol)	Interactive image;
	SMILES CCCNc1nc(nc(N(C)OC)n1)NCCC;
	InChI InChI=1S/C11H22N6O/c1-5-7-12-9-14-10(13-8-6-2)16-11(15-9)17(3)18-4/h5-8H2,1-4H3,(H2,12,13,14,15,16); Key:FJNLCHNQVJVCPY-UHFFFAOYSA-N;

ENA-001 (formerly GAL-021)

respiratory depression which can be a side effect of opioid analgesic drugs.^[5]^[6]^[7]

References

S2CID 252141895
.

PMID 24989775
.

doi:10.1096/fasebj.26.1_supplement.704.30
.

S2CID 2558991
.

doi:10.1096/fasebj.26.1_supplement.704.28
.

PMID 25343036
.

S2CID 35738816
.

v
t
e
Other respiratory system products (R07)
Lung surfactants

Colfosceril palmitate

Dipalmitoylphosphatidylcholine

Respiratory stimulants

Almitrine

Amiphenazole

Bemegride

Dimefline

Doxapram

Etamivan

GAL-021

Mepixanox

Nikethamide

Pentetrazol

Prethcamide

5-HT4 receptor agonists

BIMU-8

Zacopride

Other agents for treating respiratory depression

Ivacaftor (+ lumacaftor, + tezacaftor, + elexacaftor/tezacaftor)

Nitric oxide

BW373U86

CX-546

CX-717

drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.
v
t
e

[1] S2CID 252141895
.

[2] PMID 24989775
.

[3] :10.1096/fasebj.26.1_supplement.704.30
.

[4] S2CID 2558991
.

[5] :10.1096/fasebj.26.1_supplement.704.28
.

[6] PMID 25343036
.

[7] S2CID 35738816
.

[5]

[6]

[7]

See also

References